Principal Investigator
Cynthia Levy
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240062
Clinical Trial Summary
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Erythropoietic protoporphyria (EPP)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu